These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24628018)

  • 1. Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.
    Smith SG; Hill M; Oliveria JP; Watson BM; Baatjes AJ; Dua B; Howie K; Campbell H; Watson RM; Sehmi R; Gauvreau GM
    Immunology; 2014 Jul; 142(3):484-91. PubMed ID: 24628018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils.
    Smith SG; Imaoka H; Punia N; Irshad A; Janssen LL; Sehmi R; Gauvreau GM
    PPAR Res; 2012; 2012():235231. PubMed ID: 22966220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR agonists modulate human osteoclast formation and activity in vitro.
    Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
    Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
    Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
    Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    Chistyakov DV; Astakhova AA; Goriainov SV; Sergeeva MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human airway smooth muscle promotes eosinophil differentiation.
    Fanat AI; Thomson JV; Radford K; Nair P; Sehmi R
    Clin Exp Allergy; 2009 Jul; 39(7):1009-17. PubMed ID: 19438586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 and IL-13 differentially regulate TLR-induced eosinophil-basophil differentiation of cord blood CD34+ progenitor cells.
    Reece P; Gauvreau GM; Sehmi R; Denburg JA
    PLoS One; 2014; 9(6):e100734. PubMed ID: 24971469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor-mediated eosinophil-basophil differentiation: autocrine signalling by granulocyte-macrophage colony-stimulating factor in cord blood haematopoietic progenitors.
    Reece P; Baatjes AJ; Cyr MM; Sehmi R; Denburg JA
    Immunology; 2013 Jun; 139(2):256-64. PubMed ID: 23347362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids.
    Kuo HP; Wang CH; Lin HC; Hwang KS; Liu SL; Chung KF
    Br J Pharmacol; 2001 Dec; 134(7):1539-47. PubMed ID: 11724761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
    Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
    J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils.
    Matsuwaki Y; Ueki S; Adachi T; Oyamada H; Kamada Y; Yamaguchi K; Kanda A; Hamada K; Kayaba H; Chihara J
    Pharmacology; 2005 Jul; 74(4):169-73. PubMed ID: 15818060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
    PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
    Poleni PE; Bianchi A; Etienne S; Koufany M; Sebillaud S; Netter P; Terlain B; Jouzeau JY
    Osteoarthritis Cartilage; 2007 May; 15(5):493-505. PubMed ID: 17140817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer.
    Jahoor A; Patel R; Bryan A; Do C; Krier J; Watters C; Wahli W; Li G; Williams SC; Rumbaugh KP
    J Bacteriol; 2008 Jul; 190(13):4408-15. PubMed ID: 18178738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.